Pedro Rotllán
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pedro Rotllán has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aaron Cabrera Asensio
CEMITEC (Multidisciplinary Center for Industrial Technology), Spain
2 shared publications C.R Rodrı́guez-Ferrer
Departamento de Bioquı́mica y Biologı́a Molecular, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Canary Islands, Spain
1 shared publicationJosé S. Aguilar
Department of Neurobiology and Behavior, University of California, Irvine, USA
1 shared publicationRicardo Miledi
Department of Neurobiology and Behavior, University of California, Irvine, USA
1 shared publicationRosalina Reyes
Department of Neurobiology and Behavior, University of California, Irvine, USA
1 shared publicationS Oaknin
Departamento de Bioquı́mica y Biologı́a Molecular, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Canary Islands, Spain
1 shared publication
Latest Publications
- Open Access
- 1 March 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (5) , 1289-1297
Ectoenzymatic breakdown of diadenosine polyphosphates by Xenopus laevis oocytes
Xenopus laevis oocytes exhibit ectoenzymatic activity able to hydrolytically cleave extracellular diadenosine polyphosphates (ApnA). The basic properties of this ectoenzyme were investigated using as substrates di‐(1,N6‐ethenoadenosine) 5′,5′′′‐P1,P4‐tetraphospate [ε‐(Ap4A)] and di‐(1,N6‐ethenoadenosine) 5′,5′′′‐P1,P5‐pentaphospate [ε‐(Ap5A)], fluorogenic derivatives of Ap4A and Ap5A, respectively. ε‐(Ap4A) and ε‐(Ap5A) are hydrolysed by folliculated oocytes according to hyperbolic kinetics with Km values of 13.4 and 12.0 µm and Vmax values of 4.8 and 5.5 pmol per oocyte per min, respectively. The ectoenzyme is activated by Ca2+ and Mg2+, reaches maximal activity at pH 8–9 and is inhibited by suramin. Defolliculated oocytes also hydrolyse both substrates with similar Km values but Vmax values are approximately doubled with respect to folliculated controls. Chromatographic analysis indicates that extracellular ε‐(Ap4A) and ε‐(Ap5A) are first cleaved into 1,N6‐ethenoAMP (ε‐AMP) + 1,N6‐ethenoATP (ε‐ATP) and ε‐AMP + 1,N6‐ethenoadenosine tetraphosphate (ε‐Ap4), respectively, which are catabolized to 1,N6‐ethenoadenosine (ε‐Ado) as the end product by folliculated oocytes. Denuded oocytes, however, show a drastically reduced rate of ε‐Ado production, ε‐AMP being the main end‐product of extracellular ε‐(ApnA) catabolism. Results indicate that, whereas the ApnA‐cleaving ectoenzyme appears to be located mainly in the oocyte, ectoenzymes involved in the dephosphorylation of mononucleotide moieties are located mainly in the follicular cell layer.
- 1 March 2001
- Published by Wiley in European Journal of Biochemistry
- Vol. 268 (5) , 1289-1297
Open AccessEctoenzymatic breakdown of diadenosine polyphosphates by Xenopus laevis oocytes
Xenopus laevis oocytes exhibit ectoenzymatic activity able to hydrolytically cleave extracellular diadenosine polyphosphates (ApnA). The basic properties of this ectoenzyme were investigated using as substrates di‐(1,N6‐ethenoadenosine) 5′,5′′′‐P1,P4‐tetraphospate [ε‐(Ap4A)] and di‐(1,N6‐ethenoadenosine) 5′,5′′′‐P1,P5‐pentaphospate [ε‐(Ap5A)], fluorogenic derivatives of Ap4A and Ap5A, respectively. ε‐(Ap4A) and ε‐(Ap5A) are hydrolysed by folliculated oocytes according to hyperbolic kinetics with Km values of 13.4 and 12.0 µm and Vmax values of 4.8 and 5.5 pmol per oocyte per min, respectively. The ectoenzyme is activated by Ca2+ and Mg2+, reaches maximal activity at pH 8–9 and is inhibited by suramin. Defolliculated oocytes also hydrolyse both substrates with similar Km values but Vmax values are approximately doubled with respect to folliculated controls. Chromatographic analysis indicates that extracellular ε‐(Ap4A) and ε‐(Ap5A) are first cleaved into 1,N6‐ethenoAMP (ε‐AMP) + 1,N6‐ethenoATP (ε‐ATP) and ε‐AMP + 1,N6‐ethenoadenosine tetraphosphate (ε‐Ap4), respectively, which are catabolized to 1,N6‐ethenoadenosine (ε‐Ado) as the end product by folliculated oocytes. Denuded oocytes, however, show a drastically reduced rate of ε‐Ado production, ε‐AMP being the main end‐product of extracellular ε‐(ApnA) catabolism. Results indicate that, whereas the ApnA‐cleaving ectoenzyme appears to be located mainly in the oocyte, ectoenzymes involved in the dephosphorylation of mononucleotide moieties are located mainly in the follicular cell layer.
- 12 June 1998
- Published by Wiley in FEBS Letters
- Vol. 429 (2) , 143-146
Potent inhibition of specific diadenosine polyphosphate hydrolases by suramin
The cytosolic enzymes asymmetrical diadenosine tetraphosphate hydrolase (EC 3.6.1.17, Ap4Aase) and diadenosine triphosphate hydrolase (EC 3.6.1.29, Ap3Aase) are inhibited competitively by suramin. Ap4Aase and Ap3Aase were assayed in cytosolic rat brain extracts using fluorogenic analogues of the respective substrates diadenosine tetraphosphate (Ap4A) and diadenosine triphosphate (Ap3A). K i values for suramin as inhibitor of Ap4Aase and Ap3Aase were 5×10−6 M and 3×10−7 M, respectively. Results indicate that suramin or suramin‐like derivatives may be useful tools to investigate diadenosine polyphosphate cleaving enzymes and that the intracellular diadenosine polyphosphate metabolism may be a pharmacological target of suramin with biological and clinical implications.
- 12 June 1998
- Published by Wiley in FEBS Letters
- Vol. 429 (2) , 143-146
Potent inhibition of specific diadenosine polyphosphate hydrolases by suramin
The cytosolic enzymes asymmetrical diadenosine tetraphosphate hydrolase (EC 3.6.1.17, Ap4Aase) and diadenosine triphosphate hydrolase (EC 3.6.1.29, Ap3Aase) are inhibited competitively by suramin. Ap4Aase and Ap3Aase were assayed in cytosolic rat brain extracts using fluorogenic analogues of the respective substrates diadenosine tetraphosphate (Ap4A) and diadenosine triphosphate (Ap3A). K i values for suramin as inhibitor of Ap4Aase and Ap3Aase were 5×10−6 M and 3×10−7 M, respectively. Results indicate that suramin or suramin‐like derivatives may be useful tools to investigate diadenosine polyphosphate cleaving enzymes and that the intracellular diadenosine polyphosphate metabolism may be a pharmacological target of suramin with biological and clinical implications.